scispace - formally typeset
Open AccessJournal ArticleDOI

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

TLDR
The proposed consensus criteria will facilitate consistent diagnosis, appropriate treatment, and collaborative research and exclude infectious, malignant, and autoimmune disorders that can mimic iMCD.
About
This article is published in Blood.The article was published on 2017-03-23 and is currently open access. It has received 330 citations till now. The article focuses on the topics: Castleman disease & Hepatosplenomegaly.

read more

Citations
More filters
Journal ArticleDOI

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

TL;DR: These guidelines should help treating physicians to stratify patients based on disease severity in order to select the best available therapeutic option to improve outcomes.
Journal ArticleDOI

Overview of Castleman disease.

TL;DR: Advances in diagnosis, classification, pathogenesis, and therapy are substantial since the original description of UCD by Benjamin Castleman in 1954, and further progress will be made by continued engagement of physicians, scientists, and patients.
Journal ArticleDOI

Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.

TL;DR: Established markers of inflammation as well as cytokine levels are compared and contrasted between these four entities in order to establish a foundation for future diagnostic criteria of COVID-CSS.
Journal ArticleDOI

The full spectrum of Castleman disease: 273 patients studied over 20 years

TL;DR: The spectrum of Castleman disease (CD) has considerably extended since its first description in 1956 as mentioned in this paper, and an international collaborative working group has reached consensus on the diagnostic criteria and classification of CD.
References
More filters
Journal ArticleDOI

Revised response criteria for malignant lymphoma

TL;DR: New guidelines incorporating PET, IHC, and flow cytometry for definitions of response in non-Hodgkin's and Hodgkin's lymphoma are presented and it is hoped that they will be adopted widely by study groups, pharmaceutical and biotechnology companies, and regulatory agencies to facilitate the development of new and more effective therapies to improve the outcome of patients with lymphoma.
Journal ArticleDOI

Consensus statement on the pathology of IgG4-related disease

TL;DR: This statement proposes a terminology scheme for the diagnosis of IgG4-related disease that is based primarily on the morphological appearance on biopsy, and advocates the use of strict criteria for accepting newly proposed entities or sites as components of the IgG 4- related disease spectrum.
Journal ArticleDOI

Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV

TL;DR: Four virus proteins similar to two human macrophage inflammatory protein (MIP) chemokines, interleukin-6 (IL-6), and interferon regulatory factor (IRF) are encoded by the Kaposi's sarcoma-associated herpesvirus (KSHV) genome.
Related Papers (5)